Corrigendum: Usfda/Dgci Approved Everolimus Drug Tender - 144349158

INDIAN AIR FORCE (IAF) has floated a tender for Corrigendum: Usfda/Dgci Approved Everolimus Drug Eluting Third Generation Platinum Chromium Coronary Stent Assor, Qty: 2. The project location is Kanpur, Uttar Pradesh, India. The reference number is GEM/2026/B/7656029 and it is closing on 02 Jul 2026. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Procurement Summary

State: Uttar Pradesh

Summary: Corrigendum: Usfda/Dgci Approved Everolimus Drug Eluting Third Generation Platinum Chromium Coronary Stent Assor, Qty: 2

Deadline: 02 Jul 2026

Posting Date: 01 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144349158

Document Ref. No.: GEM/2026/B/7656029

Financier: Self Financed

Purchaser Ownership: Public

Document Fees: Refer Document

Tender Value: Refer Document

EMD: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

USFDA/DGCI approved Everolimus drug eluting third generation platinum chromium coronary stent assort
Quantity Required: 2

Start Date: 12-06-2026 11:38 AM

End Date: 02-07-2026 12:00 PM
Tender ID: GEM/2026/B/7656029

Documents

Tender Notice

Bid_Document_9458832.pdf

Download All

Corresponding Contract Award Notice